TrialBioMed research international2020
14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients.
Hong-Ye Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it